ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 148 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2020. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $26,559,000 | +1.5% | 650,000 | 0.0% | 0.52% | -8.1% |
Q1 2021 | $26,169,000 | -30.3% | 650,000 | +2.4% | 0.57% | -28.3% |
Q4 2020 | $37,548,000 | +21.6% | 635,000 | 0.0% | 0.80% | +1.5% |
Q3 2020 | $30,880,000 | +11.0% | 635,000 | +10.4% | 0.78% | +2.8% |
Q2 2020 | $27,819,000 | +83.7% | 575,000 | +5.5% | 0.76% | +21.9% |
Q1 2020 | $15,140,000 | -7.2% | 545,000 | 0.0% | 0.63% | +21.6% |
Q4 2019 | $16,306,000 | -3.2% | 545,000 | 0.0% | 0.52% | -23.2% |
Q3 2019 | $16,841,000 | -41.9% | 545,000 | -9.2% | 0.67% | -36.0% |
Q2 2019 | $28,980,000 | – | 600,000 | – | 1.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
Triatomic Management LP | 121,166 | $813,024 | 0.83% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |